Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Perrigo Wins Famotidine Complete Patent Litigation
June 26th, 2007
The Perrigo Company (NASDAQ: PRGO; TASE) announced today that a federal court has ruled in its favor in patent litigation involving Famotidine Complete. Perrigo had been sued by Johnson and Johnson's McNeil unit and its partner Merck and Company for infringement of a patent related to the formulation of Pepcid(R) Complete. However, the United States District Court for the Southern District of New York ruled yesterday that the patent is invalid. Following FDA approval, Perrigo will begin marketing Famotidine Complete under store brand and value brand labels to its customers. Perrigo's President and CEO Joseph C. Papa stated, "This is another example of Perrigo's...
Source: Drug Law Weekly (2007-06-26)
|
